UBS’s MEDGENICS INC WT PUR COM EXP 03/31/16 MDGN.WS Stock Holding History

UBS’s Portfolio MDGN.WS Stock Details MDGN.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-444	Closed	-$1K	–	11169
2014 Q1	$1K	Sell	444 -72	-14%	-$236	﹤0.01%	10295
2013 Q4	$1K	Buy	+516	New	+$1.55K	﹤0.01%	10266
2013 Q3	–	Sell	-200	Closed	–	–	11010
2013 Q2	$0	Buy	+200	New	+$263	﹤0.01%	10216

Other funds holding MDGN.WS

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

UBS's MDGN.WS Position: Q2 2014 in Review

UBS sold out of MEDGENICS INC WT PUR COM EXP 03/31/16 (MDGN.WS) in Q2 2014, closing a stake of 444 shares — an estimated $1K sold.

UBS first reported a position in MDGN.WS in Q2 2013 and held it in 3 quarters. The position peaked at $1K in Q1 2014. 1 fund tracked by Wall St. Rank holds MDGN.WS as of Q2 2014.

UBS reported no remaining MEDGENICS INC WT PUR COM EXP 03/31/16 position as of Q2 2014 after selling out during the quarter.
UBS sold 444 MEDGENICS INC WT PUR COM EXP 03/31/16 shares in Q2 2014, an estimated $1K.
UBS first reported a position in MEDGENICS INC WT PUR COM EXP 03/31/16 in Q2 2013 and held it in 3 quarters.
UBS's MEDGENICS INC WT PUR COM EXP 03/31/16 position peaked at $1K in Q1 2014.
1 fund tracked by Wall St. Rank held MEDGENICS INC WT PUR COM EXP 03/31/16 as of Q2 2014.

Based on UBS's 13F filing for Q2 2014, filed 14 Aug 2014.